/stocks — the workspaceLOADING
All REVBSEC filings, by type → · Earnings date & implied move · Search inside filings
REVELATION BIOSCIENCES, INC. (REVB) is a pharmaceutical preparations company. Next earnings projected around 2026-11-05 from REVB's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
What’s behind REVB’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
A plain-English read on REVB plus an auto-SWOT — built from REVB's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate REVB using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
No open-market Form 4 buys or sells reported for REVB in the last ~6 months.
No lawmaker has disclosed a trade in REVB under the STOCK Act.
No tracked institution reported a position in REVB in the latest 13F round.
Projected from REVB's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentREVB files or announces.
REVB has sold off after 6 of its last 8 earnings reports.
Each figure is one earnings reaction — how much REVB moved from the closing price the day before a report to the close the day after. Based on its last 8 reports.
Large earnings reactions have been common.
REVB has traded lower after most recent earnings releases.
The average is inflated by its most volatile prints (+22.4% and -9.2%).
A more typical earnings reaction has been approximately ±6.5%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-08-06 | -0.9% |
| 2026-05-07 | -5.9% |
| 2026-02-26 | -6.4% |
| 2025-11-06 | -9.2% |
| 2025-08-08 | -6.7% |
| 2025-05-08 | +9.8% |
| 2025-03-06 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| -1.1% |
| 2024-11-08 | +22.4% |